The partnership with a prestigious institution like Cleveland Clinic not only validates Anixa Biosciences' technology and approach to cancer treatment but also potentially accelerates the development and commercialization of their cancer vaccines. This collaboration could lead to significant advancements in cancer treatment, enhancing ANIX's reputation and potentially its stock price in the short term.